Fundies.
English

SeaStar Medical Holding Corporation

EDGAR
ICU Registration statement (S-3) · filed 2026-10-30

Annual consolidated revenue for 2025: about USD 1.234M, using the latest reported figures. The previous period, 2024, was about USD 135K.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments
Watchlist

Latest quarter

Revenue

600 thousand USD

2026 Q2 · USD

Exact inputs and evidence

Operating margin

-631.83%

2026 Q2 · %

Exact inputs and evidence
  • Operating Income: -3791000 USD Source
  • Revenue: 600000 USD Source

Operating cash flow

-2.99 million USD

2026 Q2 · USD

Exact inputs and evidence
  • Operating Cash Flow: -5755000 USD Source
  • Operating Cash Flow: -2761000 USD Source
Cash and cash equivalents
51.6 thousand USD Source
Exact value

51567 USD

Long-term debt including current maturities
0 USD Source
Exact value

0 USD

Shares outstanding
4.26 million shares Source
Exact value

4259842 shares

Reported share-count change

-75.44% · -13.1 million shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence
  • 17343269 shares · 2025-06-30· Source
  • 4259842 shares · 2026-06-30· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

1.7 million USD

2025-07-01 – 2026-06-30

Exact inputs and evidence
  • Revenue: 183000 USD · 2025-07-01 – 2025-09-30 Source
  • Revenue: 1234000 USD · 2025-01-01 – 2025-12-31 Source
  • Revenue: 814000 USD · 2025-01-01 – 2025-09-30 Source
  • Revenue: 495000 USD · 2026-01-01 – 2026-03-31 Source
  • Revenue: 600000 USD · 2026-04-01 – 2026-06-30 Source

Net income

-13.6 million USD

2025-07-01 – 2026-06-30

Exact inputs and evidence
  • Net income: -3472000 USD · 2025-07-01 – 2025-09-30 Source
  • Net income: -12150000 USD · 2025-01-01 – 2025-12-31 Source
  • Net income: -9246000 USD · 2025-01-01 – 2025-09-30 Source
  • Net income: -3521000 USD · 2026-01-01 – 2026-03-31 Source
  • Net income: -3730000 USD · 2026-04-01 – 2026-06-30 Source

Operating cash flow

-13.7 million USD

2025-07-01 – 2026-06-30

Exact inputs and evidence
  • Operating cash flow: -9505000 USD · 2025-01-01 – 2025-09-30 Source
  • Operating cash flow: -5661000 USD · 2025-01-01 – 2025-06-30 Source
  • Operating cash flow: -13599000 USD · 2025-01-01 – 2025-12-31 Source
  • Operating cash flow: -9505000 USD · 2025-01-01 – 2025-09-30 Source
  • Operating cash flow: -2761000 USD · 2026-01-01 – 2026-03-31 Source
  • Operating cash flow: -5755000 USD · 2026-01-01 – 2026-06-30 Source
  • Operating cash flow: -2761000 USD · 2026-01-01 – 2026-03-31 Source

Company performance

Up to ten complete financial years · consolidated figures

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2026-10-30.

Financial data available through: 2025-12-31.

Coverage by financial measure
  • Revenue: 3 of 11 periods available· newest 2025-12-31
  • Operating income: 6 of 11 periods available· newest 2025-12-31
  • Net income: 6 of 11 periods available· newest 2025-12-31
  • Operating cash flow: 6 of 11 periods available· newest 2025-12-31
  • capital expenditure: No compatible figures in this window
  • Total assets: 3 of 11 periods available· newest 2025-12-31
  • Total liabilities: 3 of 11 periods available· newest 2025-12-31
  • Current assets: 3 of 11 periods available· newest 2025-12-31
  • Current liabilities: 3 of 11 periods available· newest 2025-12-31
  • cash and cash equivalents: No compatible figures in this window
  • Long-term debt including current maturities: 1 of 11 periods available· newest 2023-12-31
  • Shares outstanding: 3 of 11 periods available· newest 2025-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

  • Revenue

    +814.1%

    Prior period

    USD 135,000

    –

    Current period

    USD 1.23 million

    –

    Exact inputs and evidence

    1234000 − 135000 = 1099000 USD

    135000 USD · 2024-01-01 – 2024-12-31

    Inspect prior input Prior source

    1234000 USD · 2025-01-01 – 2025-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

  • Net income

    +USD 12.68 million

    Prior period

    −USD 24.83 million

    –

    Current period

    −USD 12.15 million

    –

    Exact inputs and evidence

    -12150000 − -24830000 = 12680000 USD

    -24830000 USD · 2024-01-01 – 2024-12-31

    Inspect prior input Prior source

    -12150000 USD · 2025-01-01 – 2025-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

  • Operating cash flow

    +USD 2.41 million

    Prior period

    −USD 16.01 million

    –

    Current period

    −USD 13.6 million

    –

    Exact inputs and evidence

    -13599000 − -16007000 = 2408000 USD

    -16007000 USD · 2024-01-01 – 2024-12-31

    Inspect prior input Prior source

    -13599000 USD · 2025-01-01 – 2025-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Capital expenditure.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2025 2025-01-01 – 2025-12-31

  • Revenue USD 1.23 million 100% of revenue
  • Cost of revenue USD 53,000 4.3% of revenue
  • Operating expenses USD 13.36 million 1,082% of revenue
  • Operating income −USD 12.18 million −987% of revenue
  • Tax, interest and other Derived −USD 25,000 −2% of revenue
  • Net income −USD 12.15 million −985% of revenue

Cash

  • Operating cash flow −USD 13.6 million −1,102% of revenue
  • Capital expenditure Unavailable An input is unavailable.
  • Free cash flow Derived Unavailable An input is unavailable.

Share of revenue by period

  • Net income
  • Tax, interest and other
  • Operating costs
  • 2023 Not shown: operating income or net income is not reported.
  • 2024 Operating loss: operating costs were 13,316% of revenue.
  • 2025 Operating loss: operating costs were 1,087% of revenue.
Values and sources
Revenue breakdown by annual reporting period
PeriodRevenueOperating costsOperating incomeTax, interest and otherNet incomeFree cash flowSource
2023 2023-01-01 – 2023-12-310 14210000 Derived -14210000 12022000 Derived -26232000 Unavailable
Source
2024 2024-01-01 – 2024-12-31135000 17977000 Derived -17842000 6988000 Derived -24830000 Unavailable
Source
2025 2025-01-01 – 2025-12-311234000 13409000 Derived -12175000 -25000 Derived -12150000 Unavailable
Source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 1.2M 2025
Revenue historyRevenue reported for each complete financial period. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.1.3M999.5K666.4K333.2K0.0202320242025
Values and sources
Revenue values and source evidence
PeriodSeriesValue(USD)Source evidence
2023Revenue0
2024Revenue135000
2025Revenue1234000

Revenue growth

Change in revenue from the same financial period one year earlier.

814.1% 2025
Revenue growth historyChange in revenue from the same financial period one year earlier. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.879%659%440%220%0%202320242025
Values and sources
Revenue growth values and source evidence
PeriodSeriesValueSource evidence
2023Year over yearNo prior comparable period
2024Year over yearNo prior comparable period
2025Year over year814.1%

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -986.6% 2025
Net margin -984.6% 2025
Profit margins historyOperating income, net income and free cash flow as a share of revenue. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.1,471%-3,862%-9,196%-14,530%-19,864%202320242025
  • Operating margin
  • Net margin
  • Free cash flow margin
Values and sources
Profit margins values and source evidence
PeriodSeriesValueSource evidence
2023Operating marginNot reported
2024Operating margin-13,216.3%
2025Operating margin-986.6%
2023Net marginNot reported
2024Net margin-18,392.6%
2025Net margin-984.6%
2023Free cash flow marginNot reported
2024Free cash flow marginNot reported
2025Free cash flow marginNot reported

Operating cash flow

Cash generated by the company’s normal business operations.

USD -13.6M 2025
Operating cash flow historyCash generated by the company’s normal business operations. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.1.3M-3.4M-8.0M-12.6M-17.3M202320242025
Values and sources
Operating cash flow values and source evidence
PeriodSeriesValue(USD)Source evidence
2023Operating cash flow-10285000
2024Operating cash flow-16007000
2025Operating cash flow-13599000

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

Not enough comparable data to show this history.
Values and sources
Free cash flow values and source evidence
PeriodSeriesValue(USD)Source evidence
2023Free cash flowUnavailable
2024Free cash flowUnavailable
2025Free cash flowUnavailable

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

26.4% 2025
Liabilities to assets historyTotal liabilities as a share of total assets. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.536%402%268%134%0%202320242025
Values and sources
Liabilities to assets values and source evidence
PeriodSeriesValueSource evidence
2023Liabilities / assets496.7%
2024Liabilities / assets145.6%
2025Liabilities / assets26.4%

Current assets to current liabilities

Current assets divided by current liabilities.

3.63× 2025
Current assets to current liabilities historyCurrent assets divided by current liabilities. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.3.92×2.94×1.96×0.98×0.00×202320242025
Values and sources
Current assets to current liabilities values and source evidence
PeriodSeriesValueSource evidence
2023Current assets / current liabilities0.18×
2024Current assets / current liabilities0.55×
2025Current assets / current liabilities3.63×

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
PeriodNet incomeOperating cash flowCapital expenditureFree cash flow
2020 2020-01-01 – 2020-12-31
−USD 3.3 million
Exact value

Exact value: -3300000 USD

2020-01-01 – 2020-12-31: -3300000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 5.57 million
Exact value

Exact value: -5572000 USD

2020-01-01 – 2020-12-31: -5572000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unavailable Not reported for this period.
Unavailable

Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

2021 2021-01-01 – 2021-12-31
−USD 4.6 million
Exact value

Exact value: -4596000 USD

2021-01-01 – 2021-12-31: -4596000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 5.11 million
Exact value

Exact value: -5114000 USD

2021-01-01 – 2021-12-31: -5114000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unavailable Not reported for this period.
Unavailable

Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

2022 2022-01-01 – 2022-12-31
−USD 12.19 million
Exact value

Exact value: -12190000 USD

2022-01-01 – 2022-12-31: -12190000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 7.79 million
Exact value

Exact value: -7794000 USD

2022-01-01 – 2022-12-31: -7794000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unavailable Not reported for this period.
Unavailable

Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

2023 2023-01-01 – 2023-12-31
−USD 26.23 million
Exact value

Exact value: -26232000 USD

2023-01-01 – 2023-12-31: -26232000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 10.29 million
Exact value

Exact value: -10285000 USD

2023-01-01 – 2023-12-31: -10285000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unavailable Not reported for this period.
Unavailable

Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

2024 2024-01-01 – 2024-12-31
−USD 24.83 million
Exact value

Exact value: -24830000 USD

2024-01-01 – 2024-12-31: -24830000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 16.01 million
Exact value

Exact value: -16007000 USD

2024-01-01 – 2024-12-31: -16007000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unavailable Not reported for this period.
Unavailable

Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

2025 2025-01-01 – 2025-12-31
−USD 12.15 million
Exact value

Exact value: -12150000 USD

2025-01-01 – 2025-12-31: -12150000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 13.6 million
Exact value

Exact value: -13599000 USD

2025-01-01 – 2025-12-31: -13599000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unavailable Not reported for this period.
Unavailable

Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

49 filings · 1,342 latest values · 1,342 originally reported values

Dataset published . Source filing dates and reporting periods are shown separately.

Identifiers: 0001831868, 1831868, ICU, ICUCW, edgar:1831868

Also known as LMF ACQUISITION OPPORTUNITIES INC., LMF Acquisition Opportunities Inc, SEASTAR MEDICAL HOLDING CORPORATION, SeaStar Medical Holding Corp, SeaStar Medical Holding Corporation